IKNA Chart
- 52-Week Range: $3.57 - $19.77
- Market Capitalization: $154.87M
- Short Percentage: 0%
- Target Price: $24.33
- Shares Outstanding: 36.16M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
IKNA released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Ikena Oncology Reports First Quarter 2022 Financial Results and Provides a Corporate UpdateGlobeNewsWire | May 12th
- Ikena Oncology to Present at the American Society of Clinical Oncology (ASCO) 2022 Annual MeetingGlobeNewsWire | April 28th
- Ikena Oncology to Participate in Cowen 42nd Annual Health Care ConferenceGlobeNewsWire | March 1st
- Ikena Appoints Michelle Zhang, Ph.D., Industry and Company Veteran, as Chief Scientific OfficerGlobeNewsWire | December 8th
- Ikena Oncology Reports Third Quarter 2021 Financial Results and Corporate UpdateGlobeNewsWire | November 10th
- Ikena Oncology Announces FDA Acceptance of IND Application of Novel TEAD Inhibitor IK-930GlobeNewsWire | November 2nd
- Ikena Oncology to Participate in September 2021 Virtual Investor ConferencesGlobeNewsWire | September 2nd
Company Info
Website: https://ikenaoncology.com
Address: 645 Summer Street, Boston, MA, United States, 02210
Sector: N/A
Industry: N/A
Full time employees: 67
Address: 645 Summer Street, Boston, MA, United States, 02210
Sector: N/A
Industry: N/A
Full time employees: 67
$IKNA death cross will complete today
$IKNA Green by EOD guarentee
$IKNA shorters eat my shit
$IKNA we’re fucked tomorrow boys
$IKNA low volume today isn’t necessarily a bad thing
$IKNA I bought the dip
$IKNA has just been halted from trading due to volatility.